3 ms·
It is good isn't it. I just re-read it ten years after the original publication. I googled and Perron's start-up GeNeuro is still going, trying to fix MS with
by tim333 7y ago
It is good isn't it. I just re-read it ten years after the original publication.
I googled and Perron's start-up GeNeuro is still going, trying to fix MS with an antibody against HERV-W. https://www.fiercebiotech.com/biotech/geneuro-raises-eu17-5m-for-multiple-sclerosis-clinical-trial https://www.fiercebiotech.com/biotech/geneuro-raises-eu17-5m...